|  | |||||
| ||||||
By Dr. Bejoy Daniel, Industry Analyst, Healthcare
New surgical procedures for head and neck cancer offers improved accuracy for surgeons and reduced post-operative pain for patients. These new procedures use robotic surgery, and results have shown it lessens the scarring, breathing problems and damage to speech that usually happens with head and neck procedures. Initial tests have also shown that such new procedures in addition shorten recovery times for cancer patients.
Market ScenarioConclusion:
Accuray has been keen in developing the most advanced robotic radiosurgery system to treat tumors anywhere in the body with the highest levels of accuracy. Currently Accuray has 130 CyberKnife Systems installed worldwide with a large body of peer-reviewed papers supporting its clinical practice.
Despite Accuray's product positioning within the radiation therapy market as a specialty player in the area of robotic radiosurgery, the company is expected to grow significantly above the market. However, they are expected to face competition from competitors with a broader product offering, along with pricing pressure as key inhibitors to the company achieving the brand appeal of larger players such as Elekta and Varian.
Posts
No comments:
Post a Comment